Vallon Pharmaceuticals Inc (VLON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VLON | AZN | AMGN | GILD | BMY |
| Company | Vallon Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.4200 | 202.81 | 354.25 | 138.05 | 60.00 |
| High | 0.4308 | 203.37 | 356.90 | 138.54 | 60.12 |
| Low | 0.3803 | 200.67 | 350.02 | 135.48 | 58.91 |
| Latest | 0.4000 | 200.69 | 350.16 | 135.87 | 59.13 |
| Change | -0.0600 | -4.11 | -5.14 | -1.77 | -1.04 |
| % Change | -13.04% | -2.01% | -1.45% | -1.29% | -1.73% |
| Volume | 1,113,400 | 1,104,500 | 2,107,600 | 3,871,200 | 7,678,000 |
| 20-Day Average Volume | 734,190 | 1,863,870 | 2,463,350 | 5,312,250 | 9,907,780 |
| Previous Close | 0.4600 | 204.80 | 355.30 | 137.64 | 60.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4018 | 197.74 | 349.95 | 138.67 | 58.98 |
| 20-Day Raw Stochastic | 34.78% | 73.46% | 61.92% | 21.81% | 46.41% |
| 20-Day Relative Strength | 48.75 | 53.47 | 47.14 | 42.47 | 50.60 |
| Weighted Alpha | -68.20 | +43.25 | +23.89 | +28.57 | +27.32 |
| Today's Opinion | 48% Buy | 88% Buy | 56% Buy | 40% Buy | 64% Buy |
| Previous Opinion | 48% Buy | 88% Buy | 56% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 56% Buy | 56% Buy | 56% Buy | 64% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.50% since 04/14/23 | -0.77% since 04/13/26 | +0.10% since 04/13/26 | -2.27% since 04/13/26 | +1.84% since 04/13/26 |
| Low | 0.3622 on 04/17/23 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 135.48 on 04/20/26 | 57.22 on 04/15/26 |
| High | 0.5500 on 04/20/23 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | -2.70% since 03/21/23 | +9.31% since 03/20/26 | +0.68% since 03/20/26 | -0.98% since 03/20/26 | +2.87% since 03/20/26 |
| Low | 0.3200 on 04/05/23 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.5500 on 04/20/23 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +36.75% since 01/20/23 | +11.57% since 01/20/26 | +5.79% since 01/20/26 | +9.45% since 01/20/26 | +9.06% since 01/20/26 |
| Low | 0.2562 on 01/26/23 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 53.54 on 01/21/26 |
| High | 1.2300 on 02/13/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +24.22% since 10/21/22 | +19.64% since 10/20/25 | +15.44% since 10/20/25 | +10.36% since 10/20/25 | +35.65% since 10/20/25 |
| Low | 0.2054 on 10/28/22 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 1.2300 on 02/13/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,393 | 317,625,952 | 191,750,080 | 170,841,792 | 122,851,192 |
| Shares Outstanding, K | 13,482 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -7,020,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -1,583,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -1.14 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 02/24/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/08/23 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.89 | 15.99 | 17.00 | 9.59 |